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untingtin-interacting protein 1 related (Hip1R) is a
novel component of clathrin-coated pits and vesicles
and is a mammalian homologue of Sla2p, an actin-
binding protein important for both actin organization and
endocytosis in yeast. Here, we demonstrate that Hip1R
binds via its putative central coiled-coil domain to clathrin,
and provide evidence that Hip1R and clathrin are associated
in vivo at sites of endocytosis. First, real-time analysis of
Hip1R–YFP and DsRed–clathrin light chain (LC) in live
cells revealed that these proteins show almost identical
temporal and spatial regulation at the cell cortex. Second,
at the ultrastructure level, immunogold labeling of ‘unroofed’
H
 
cells showed that Hip1R localizes to clathrin-coated pits.
Third, overexpression of Hip1R affected the subcellular
distribution of clathrin LC. Consistent with a functional
role for Hip1R in endocytosis, we also demonstrated that
it promotes clathrin cage assembly in vitro. Finally, we
showed that Hip1R is a rod-shaped apparent dimer with
globular heads at either end, and that it can assemble
clathrin-coated vesicles and F-actin into higher order
structures. In total, Hip1R’s properties suggest an early
endocytic function at the interface between clathrin, F-actin,
and lipids.
 
Introduction
 
Endocytosis is critically important for downregulation of
growth factor signaling, nutrient uptake, antigen presenta-
tion, pathogen internalization, and maintenance of plasma
membrane surface area. During receptor-mediated endocy-
tosis, clathrin is recruited to the plasma membrane where it
assembles on the lipid bilayer to form coated pits (for review
see Marsh and McMahon, 1999; Brodin et al., 2000).
Coated pits contain not only clathrin and receptors but also
proteins that can promote clathrin polymerization and in
some cases bind to the receptors (e.g., AP2 and AP180)
(Ungewickell and Oestergaard, 1989; Keen, 1990). Coated
pits subsequently invaginate and pinch off from the plasma
membrane as clathrin-coated vesicles (CCVs)* in a dy-
namin-dependent manner (for review see Sever
 
 
 
et al
 
.
 
, 2000).
In addition to clathrin, AP2, AP180/CALM, and dyna-
min, other proteins, including amphiphysin, synaptojanin,
Eps15, epsin, endophilin, auxilin, cyclin G–associated ki-
nase (GAK), syndapin, intersectin, and Abp1, all have been
implicated in the early stages of endocytosis (for review see
Brodin et al., 2000; Jarousse and Kelly, 2001; see also Kes-
sels et al., 2001). Furthermore, evidence is emerging that
both phospholipids and the actin cytoskeleton, which are in-
tegral parts of the cell cortex, are involved in endocytosis in
mammalian cells (for review see Qualmann
 
 
 
et al
 
.
 
, 2000;
Cremona and De Camilli, 2001).
A few molecular candidates that could function at the
interface between actin and the endocytic machinery have
been identified recently in mammalian cells (for review see
Qualmann et al., 2000). One of these proteins is the hun-
tingtin-interacting protein 1 related (Hip1R), a component
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of clathrin-coated pits and vesicles that binds to F-actin (Eng-
qvist-Goldstein
 
 
 
et al
 
.
 
, 1999). Hip1R belongs to a conserved
family of proteins that includes yeast Sla2p/End4p, a protein
essential for both endocytosis and actin functions (Holtzman
et al
 
.
 
, 1993; Wesp
 
 
 
et al
 
.
 
, 1997; Yang
 
 
 
et al
 
.
 
, 1999), and Hip1,
a protein implicated in the pathology of Huntington’s dis-
ease (Kalchman et al., 1997; Wanker et al., 1997). Genetic
and biochemical data have suggested that Sla2p and other
cortical actin patch proteins function at an early stage of en-
docytosis in yeast (for review see Wendland
 
 
 
et al
 
.
 
, 1998).
Members of the Sla2/Hip1 family have a conserved domain
structure. At the NH
 
2 
 
terminus, they contain a domain related
to the epsin NH
 
2
 
-terminal homology domain (ENTH) found
in several proteins implicated in endocytosis, including epsins
and AP180/CALM, as well as their yeast homologues (Kay
 
 
 
et
al
 
.
 
, 1999; McCann and Craig, 1999). Recently, it has been
shown that the ENTH domains of CALM and epsin bind
to phosphatidylinositol-4, 5-biphosphate (PI(4,5)P
 
2
 
) at the
plasma membrane (Ford
 
 
 
et al
 
.
 
, 2001; Itoh
 
 
 
et al
 
.
 
, 2001). The
NH
 
2
 
-terminal region of Hip1R is followed by a putative
coiled-coil region of 
 

 
300 amino acids, containing a short leu-
cine zipper that in yeast Sla2p has been implicated in endocyto-
sis and dimerization (Wesp et al., 1997; Yang et al., 1999). Fi-
nally, at the COOH terminus, these proteins contain two
shorter predicted coiled-coils and a talin-like F-actin binding
module (McCann and Craig, 1997, 1999; Engqvist-Goldstein
et al., 1999; Yang et al., 1999).
Our previous data demonstrated that Hip1R is enriched
in CCVs and colocalizes with markers for receptor-mediated
endocytosis (Engqvist-Goldstein et al., 1999). We found
that the NH
 
2
 
-terminal region plus the coiled-coil domain
are sufficient for localizing Hip1R to the endocytic machin-
ery. Since Hip1R binds to F-actin via its COOH-terminal
talin-like domain, it could thereby recruit F-actin to the en-
docytic machinery, or vice versa. To learn more about the
function of Hip1R in endocytosis and how it interacts with
the endocytic machinery, we set out to identify proteins that
bind to Hip1R.
 
Results
 
Hip1R associates with clathrin in vivo
 
To identify proteins that interact with Hip1R, we per-
formed immunoprecipitation experiments and affinity
chromatography. Fig. 1 a shows that clathrin coimmuno-
precipitated with Hip1R from a microsomal fraction pre-
pared from mouse brain extract (lane 4). This interaction
appears specific since clathrin was not detected using beads
alone (lane 2), preimmune guinea pig serum (unpublished
data), or anti-Eps15 antibodies (lane 6). However, clath-
rin was detected in immunoprecipitations using antisera
against the known clathrin-binding protein 
 

 
-adaptin
(lane 8). Similar results were obtained using affinity chro-
matography. Clathrin from brain extract was specifically
retained on a column containing His
 
6
 
-tagged Hip1R (un-
published data).
When Hip1R–green fluorescent protein (GFP) and
Hip1R–myc were coexpressed in Cos-7 cells, clathrin coim-
munoprecipitated with both proteins, consistent with the re-
sults with endogenous brain proteins. Furthermore, Hip1R–
 
myc coimmunoprecipitated with Hip1R–GFP (Fig. 1 b,
lane 3), suggesting that Hip1R is a dimer (see below).
We had observed previously that buffer containing 0.5 M
Tris-HCl dissociates Hip1R from CCVs (unpublished
data). 0.5 M Tris-HCl is also known to disassemble clathrin
Figure 1. Coimmunoprecipitation of clathrin and Hip1R from an 
extract prepared from a mouse brain microsomal pellet (a) and 
from Cos-7 cell homogenate (b). Western blotting of different 
immunoprecipitation reactions. Antibodies used for immunoprecip-
itations are indicated at the top of each blot, while antibodies used 
to probe the blot are shown on the left side. (a) Lanes 1 and 2 show 
beads alone, lanes 3 and 4 show immunoprecipitation of Hip1R, 
lanes 5 and 6 show immunoprecipitation of Eps15, and lanes 7 and 
8 show immunoprecipitation of -adaptin. Lane 9 shows the 
amount of each protein in the extract. Equal portions of supernatant 
(S) and pellet (P) were loaded. (b) Lane 1 shows the extract and 
lanes 2–4 show pellets. Lane 2 shown beads alone, lane 3 shows 
immunoprecipitation of Hip1R–GFP, and lane 4 shows immuno-
precipitation of Hip1R–GFP when beads where washed with 0.5 M 
Tris-HCl (W). The immunoprecipitations were performed three 
times with similar results.
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cages into triskelions (Zaremba and Keen, 1983). To test
whether 0.5 M Tris-HCl affects the interaction between
clathrin and Hip1R, and/or the apparent Hip1R–Hip1R
interaction, the immunoprecipitates were washed with a
buffer containing 0.5 M Tris-HCl. As shown in Fig. 1 b,
much less clathrin was detected in the immunoprecipitates
that were washed with 0.5 M Tris-HCl (compare lanes 3
and 4). However, the interaction between Hip1R–GFP and
Hip1R–myc was unaffected (compare lanes 3 and 4). In to-
tal, these results demonstrate that Hip1R is part of a com-
plex with clathrin in vivo, and suggest that at least a pool of
Hip1R exists in a complex with itself.
 
Hip1R binds to clathrin directly
 
To test whether Hip1R interacts directly with clathrin, full-
length Hip1R was expressed in SF9 cells with an His
 
6
 
 tag at
the NH
 
2
 
 terminus, purified, and tested for clathrin binding
using a clathrin cage–pelleting assay. Hip1R pelleted with
clathrin cages in a specific, saturable, and concentration-
dependent manner (Fig. 2 a). This interaction is unlikely to
be mediated through another protein since the purity of
clathrin was very high with no detectable levels of AP2, as
determined by analysis on Coomassie-stained gels and by
Western blotting (Fig. 2 a, lane 9 and unpublished data).
Furthermore, the purity of Hip1R was also high (Fig. 2 a,
Figure 2. Hip1R binds directly to clathrin cages with high affinity. 
(a) Coomassie-stained gel of a clathrin cage–pelleting assay. Lane 1 
shows total amount of recombinant His6–Hip1R (100 nM final). 
Lanes 2–8 show pellets from reactions containing 250, 150, 100, 50, 
25, 12.5, and 0 nM of clathrin cages with a constant concentration 
of His6–Hip1R (100 nM). Lane 9 shows the purity of the purified 
clathrin used in this pelleting assay. (b) The graph shows the 
percentage of His6–Hip1R bound to clathrin cages as a function of 
clathrin concentration. In this experiment, 0–20 nM of clathrin 
cages was used with a constant concentration of Hip1R (8 nM). The 
bound Hip1R was detected by Western blotting and quantified by 
densitometry. The data shown are representative of three indepen-
dent experiments. (c) Hip1R does not bind to GST-TD of clathrin 
HC (amino acids 1–579) immobilized on glutathione-agarose beads (Coomassie stained gel). Lane 1 shows the total amount of recombinant 
His6–Hip1R (100 nM final) added. Lane 2 shows a pellet of glutathione-agarose incubated with GST (500 nM) and His6–Hip1R (100 nM). 
Lane 3 shows a pellet of glutathione-agarose incubated with GST-TD (500 nM) and His6–Hip1R (100 nM). (d) Clathrin LC restores Hip1R 
binding to truncated cages. Coomassie-stained gel of a clathrin cage–pelleting assay (top). Western blot of Hip1R (bottom). Lanes 1 and 2 
show truncated cages and truncated cages reconstituted with intact clathrin LCs, respectively. Lane 3 shows the total amount of recombinant 
His6–Hip1R (200 nM final) added to the cages. Lane 4 shows Hip1R alone (200 nM). Lane 5 shows truncated cages (400 nM) with 
His6–Hip1R (200 nM). Lane 6 shows truncated cages reconstituted with LC (400 nM) with His6–Hip1R (200 nM).
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Figure 3. The central coiled-coil region of Hip1R binds to clathrin 
in vitro and in vivo. (a) Schematic diagrams of Hip1R domains 
expressed. (b) Coomassie-stained gel of the cage-pelleting assays. 
(T) shows the total amount of protein added in the assay, () 
represents pelleting without clathrin cages, and () represents 
pelleting with clathrin cages. For each assay, 600 nM of clathrin 
cages was used with 200 nM of HipR constructs. Because 
GST–Hip1R (amino acids 1–312) was partially degraded, a higher 
concentration of this construct was added to give 200 nM of 
nondegraded GST–Hip1R (amino acids 1–312). GST alone and 
His6LacI were used at 400 nM. (c) Graphical representation of results from cage-pelleting assays. The graph shows the percentage of Hip1R 
fragments pelleting with or without clathrin cages using data from three independent experiments. Error bars denote SE. (d) Endogenous 
clathrin specifically coimmunoprecipitated with Hip1R (amino acids 325–655)-6myc from Cos-7 cell extracts (lane 3). Clathrin was not 
detected using beads alone (lanes 2 and 6) or when Hip1R (amino acids 1–324)-6myc was immunoprecipitated (lane 7). The clathrin–Hip1R 
interaction was diminished when the beads were washed with buffer containing 0.5 M Tris-HCl (lane 4). Lanes 1 and 5 show extracts and 
lanes 2–4 and lanes 6 and 7 show pellets. (e–g and enlargements) Indirect immunofluorescence of endogenous clathrin HC (red) and myc-
tagged Hip1R constructs (green) in Cos-7 cells. (e) Hip1R (amino acids 1–324)-6myc. (f) Hip1R (amino acids 325–655)-6myc. (g) Hip1R 
(amino acids 1–655)-6myc. Bar, 10 m.
 
lane 1). Antibodies made against either the first 28 amino
acids or the last 37 amino acids of Hip1R recognize a dou-
blet at 
 

 
115 kD (unpublished data). Therefore, the lower
band is likely to be untagged Hip1R. Hip1R pelleting was
not due to the His tag since His-LacI did not copellet with
clathrin cages (Fig. 3 b). Since the data in Fig. 2 a suggested
that in this experiment clathrin was saturated with Hip1R,
we lowered the concentration of clathrin and Hip1R to esti-
mate the dissociation constant (Kd) for this interaction.
Clathrin cages (0–20 nM) were pelleted with a constant
concentration of Hip1R (8 nM), and binding was detected
by Western blotting. As shown in Fig. 2 b, Hip1R binds to
clathrin cages with a Kd in the low nanomolar range.
To map the Hip1R binding domain of clathrin, we first
tested whether Hip1R binds to the terminal domain (TD) of
clathrin heavy chain (HC) (amino acids 1–579). As shown in
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Fig. 2 c, Hip1R did not copellet with GST-TD. We next tested
whether Hip1R copellets with clathrin cages that have been
subjected to limited tryptic digestion. This treatment hydro-
lyzes clathrin LCs and cleaves the 192-kD HCs, resulting in re-
lease of the globular 50-kD TD (Kirchhausen and Harrison,
1981). The remainder of the HCs, comprising the hub, proxi-
mal leg, and a portion of the distal leg (truncated cages), remain
assembled and readily sedimentable (Murphy and Keen, 1992).
As shown in Fig. 2 d, binding of Hip1R to truncated cages
(lane 5) was undetectable. Reconstitution of truncated cages
with intact clathrin LCs (Ungewickell and Oestergaard, 1982)
restored binding of Hip1R to these cages (Fig. 2 d, lane 6).
 
The central coiled-coil domain of Hip1R binds
to clathrin
 
To map the clathrin binding domain of Hip1R, several
Hip1R truncation mutants were expressed in 
 
Escherichia coli
 
or in Sf-9 cells (Fig. 3 a). Most of these mutants were
expressed as stable proteins (Fig. 3 b, lanes labelled T), al-
though GST–Hip1R (amino acids 1–312) was partially de-
graded to GST. His
 
6
 
–Hip1R (amino acids 1–1068), His
 
6
 
–
Hip1R (amino acids 1–655), and His
 
6
 
–Hip1R (amino acids
346–1068) all pelleted with clathrin cages (Fig. 3, b, top,
lanes 3, 6, and 9, and c), suggesting that amino acids 346–
655 contain a clathrin binding domain. To verify that
Hip1R (amino acids 346–655), which contains the putative
 
coiled-coil domain, binds to clathrin, we also tested whether
this domain alone can bind to clathrin. Fig. 3, b, bottom,
lane 6, and c show that GST–Hip1R (amino acids 346–
655) specifically copelleted with clathrin cages, whereas
other Hip1R domains did not.
We next tested whether the putative coiled-coil domain of
Hip1R interacts with clathrin in vivo. Hip1R (amino acids
325–655)-6myc and Hip1R (amino acids 1–324)-6myc
were expressed in Cos-7 cells and immunoprecipitated using
an anti-myc antibody. As shown in Fig. 3 d, endogenous
clathrin coimmunoprecipitated with Hip1R (amino acids
325–655)-6myc (lane 3). This interaction appears to be
specific since clathrin was not detected using beads alone
(lane 2), or in immunoprecipitates of Hip1R (amino acids
1–324)-6myc (lane 7). As for full-length Hip1R, 0.5 M
Tris-HCl disrupted the interaction between clathrin and the
putative coiled-coil domain of Hip1R (lane 4). Since full-
length Hip1R was not detected in immunoprecipitates with
Hip1R (amino acids 325–655)-6myc, the interaction be-
tween clathrin and the coiled-coil domain is unlikely to be
mediated through endogenous Hip1R (unpublished data).
We also tested whether the coiled-coil domain of Hip1R
colocalizes with clathrin in Cos-7 cells. Although the NH
 
2
 
-
terminal region that contains the ENTH-like domain fol-
lowed by a conserved region (amino acids 1–324)-6myc
showed no colocalization with clathrin (Fig. 3 e; Engqvist-
Goldstein et al., 1999), the coiled-coil (amino acids 325–
655)-6myc domain partially colocalized with clathrin in
cells expressing this domain at intermediate to high levels
(Fig. 3 f). At low expression levels, there was very little colo-
calization (unpublished data). However, Hip1R (amino ac-
ids 1–655)-6myc showed an almost perfect colocalization
with clathrin, similar to full-length Hip1R (Fig. 3 g; Eng-
qvist-Goldstein et al., 1999). We have reported previously
that when the Hip1R NH
 
2
 
-terminal region (amino acids
1–324) is expressed in cells, it shows primarily cytosolic and
nuclear localization (Engqvist-Goldstein et al., 1999). Upon
closer examination, we also found that this construct local-
izes to patches at the cell cortex that are quite a bit larger
than clathrin puncta (see arrowheads in Fig. 3 e). As indi-
cated above, these patches do not colocalize with clathrin. In
summary, the putative coiled-coil domain of Hip1R inter-
acts with clathrin in vitro and in vivo.
 
Hip1R and clathrin show similar dynamics at the 
cortex in living cells
 
The dynamics of coated pit formation in live cells have been
described (Gaidarov
 
 
 
et al
 
.
 
, 1999) by observing the behavior of
GFP–clathrin LC isoform a (LCa) at the cell cortex. To gain
further insight into the temporal and spatial regulation of
Hip1R in comparison to clathrin during coated pit assembly,
we observed the behavior of Hip1R–GFP or Hip1R–YFP and
DsRed–clathrin LCa in live cells. Hip1R–GFP appears func-
tional, since at low expression it shows similar localization to
endogenous Hip1R (Engqvist-Goldstein et al., 1999), it
coimmunoprecipitates with clathrin (Fig. 1 b), and does not
appear to affect transferrin internalization (unpublished data).
DsRed-clathrin LCa appears functional since it colocalizes
with endogenous clathrin and has no apparent effects on en-
docytosis (unpublished data).
Figure 3 (continued).
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Hip1R and clathrin show an almost identical localization
pattern in punctate structures on the cell cortex in live Cos-
7 cells (Fig. 4, a–c). Hip1R overlapped with clathrin in
98% of the puncta counted (
 
n
 
 
 

 
 300). Similar results were
obtained in other cell types, including HeLa and CHO
cells (unpublished data). Approximately 85% of these
structures are bona fide clathrin-coated pits, whereas the
remaining structures are either CCVs or coated buds on
endosomes (unpublished data). Since Hip1R colocalizes
with internalized transferrin after a few minutes of uptake
and is enriched in CCVs (Engqvist-Goldstein et al., 1999),
it is likely that Hip1R also associates with clathrin in these
compartments. We have shown previously that Hip1R–
GFP exhibits similar behavior to that reported for puncta
labeled with DsRed–clathrin-LCa at the cortex in Cos-7
cells (Engqvist-Goldstein et al., 1999; Gaidarov et al.,
1999). That is, in both cases the majority of puncta re-
mained relatively stationary, but their signal intensities
changed dramatically, with puncta appearing and disap-
pearing over time. The appearance of clathrin puncta at the
cortex is likely to reflect assembly of coated pits and the
subsequent disappearance may result when coated vesicles
pinch off from the plasma membrane and are uncoated
(Gaidarov et al., 1999). By observing clathrin and Hip1R
in the same cell, we could now determine whether Hip1R
appears and disappears together with clathrin. We observed
individual puncta at the cell cortex at 2–4 s intervals for 60
frames. The lag in switching between Hip1R and clathrin
fluorescence was between 1 and 2 s. At this time resolution,
Hip1R and clathrin appear and disappear together (Fig. 4,
d–f and Video 1, available at http://www.jcb.org/content/
vol154/issue6). Out of 25 newly appearing clathrin puncta,
Hip1R appeared when clathrin appeared 25 times. Out of
25 disappearing clathrin puncta, Hip1R disappeared when
clathrin disappeared 25 times.
 
Hip1R localizes ultrastructurally to clathrin-coated pits 
in vivo, as revealed by immunogold labeling of 
unroofed cells, and appears to be an elongated dimer
 
The fact that Hip1R and clathrin show very similar temporal
and spatial regulation in live cells suggested that Hip1R is re-
cruited to the plasma membrane during formation of clath-
rin-coated pits. To investigate this possibility further, we de-
termined the localization of endogenous Hip1R using an
immunogold labeling technique in which clathrin-coated
pits and vesicles are visualized at the plasma membrane of
“unroofed cells” (Heuser, 2000b). Anti-Hip1R antibodies la-
beled clathrin-coated pits specifically in PC12 cells (Fig. 5,
a–j) and Cos-7 cells (Fig. 5, k–m). Fig. 5, b and k show
Hip1R labeling of flat lattices, which presumably represent
Figure 4. Time-lapse video microscopy of Hip1R–YFP and DsRed–clathrin-LCa in live cells. These proteins display almost identical 
behavior at the cell cortex. Images were taken at 3 s intervals over 60 frames, where the lag between Hip1R and clathrin visualization is 
1.5 s. (a–c) These images show a low magnification overview of a Cos-7 cell coexpressing Hip1R–YFP (green) and DsRed–clathrin-LCa (red). 
(a) Hip1R–YFP. (b) DsRed–clathrin-LCa. (c) Merge. (d–f) Selected images at the indicated times show that Hip1R–YFP and DsRed–clathrin-
LCa appear (arrow) and disappear (arrowhead) at the same sites with indistinguishable timing. (d) Hip1R–YFP. (e) DsRed-clathrin-LCa. 
(f) Merge. A video containing images from this figure is available at http://www.jcb.org/content/vol154/issue6. Bar, 5 m.
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early stages of coat assembly, whereas Fig. 5, c–g, l, and m
show Hip1R labeling of more deeply invaginated coated pits,
which presumably represent later stages of coat remodeling,
before the coated vesicles pinch off from the plasma mem-
brane. In some cases, anti-Hip1R antibodies also labeled fila-
Figure 5. Hip1R localizes to clathrin-coated pits in vivo. 
Anaglyph stereo view of the inner surface of “unroofed” PC12 or 
Cos-7 cells that have been subjected to indirect EM immunocy-
tochemistry with anti-Hip1R primary antibodies and 15 nm gold-
tagged secondary antibodies. (a–j) PC12 cells. (k–m) Cos-7 cells. 
(a) A field showing the inner surface of the plasma membrane. Two 
clathrin-coated pits are labeled with gold (yellow dots). The inset 
shows a three-dimensional image of a Hip1R molecule at the same 
magnification absorbed on mica and visualized by quick-freeze, 
deep-etch electron microscopy (see also Fig. 6). (b and k) Hip1R 
labeling of a two-dimensional clathrin lattice. (c–g and l) Hip1R 
labeling of invaginated coated pits. (h–j, k, and m) In some cases, 
anti-Hip1R antibodies also labeled filamentous structures that 
appeared connected to the coated pits. Magnification, 75,000.
 
mentous structures that appeared to connect the coated pits
to adjacent actin filaments (Fig. 5, h–j, k, and m).
To better understand Hip1R’s structure and how this
might relate to its function, as well as to determine what
Hip1R might look like in in situ images like those shown in
Fig. 5, a–m, we visualized the structure of highly purified
Hip1R using the deep-etch technique, wherein macromole-
cules are adsorbed to mica in preparation for freeze drying
and EM imaging (Heuser, 1983, 1989a). As shown in Fig. 6,
row 1–3, Hip1R appears to be very elongated and dimeric.
Its size is clearly too large to be a single copy of a 120-kD
protein. Its total length is 
 

 
60 nm (
 

 
7 nm), which is com-
parable to that of the motor molecules kinesin (
 

 
360 kD)
(Fig. 6, row 4) and myosin II (
 

 
450 kD) (Fig. 6, row 5). In-
deed, when fully extended and adsorbed to mica, Hip1R is
only slightly shorter than the diameter of a CCV (Fig. 5 a, in-
set). Of course, we do not yet know its actual conformation
in situ
 
.
 
 Its elongated central shaft measures 
 

 
40 nm (
 

 
6
nm). This is presumably the central coiled-coil domain that
binds to clathrin, since a 300 amino acid coiled-coil domain
would be predicted to span 
 

 
45 nm. At each end of the cen-
tral shaft are found pairs of globular heads that look the same
at each end, but different at the opposite ends, indicating
that the molecule is a parallel dimer. At one end the heads
tend to lie side by side and measure 7 to 8 nm in diameter,
whereas on the other end they lie in more variable positions
relative to each other and measure 8–10 nm in diameter.
One set of these globular heads is presumably a pair of NH
 
2
 
-
terminal regions containing the ENTH-like domain, whereas
the other set is presumably a pair of the COOH-terminal re-
gions containing the talin-like actin binding domain. How-
ever, we have not as yet determined which end is which. In
addition to the elongated conformation, we also observed
Hip1R molecules that appeared kinked (Fig. 6, row 6), a fea-
ture also shared with kinesin (Fig. 6, row 7; Hisanaga et al.,
1989). Secondary structure predictions suggest a break in the
central coiled-coil of Hip1R that may serve as a hinge region
(Yang et al., 1999; Chopra et al., 2000).
The fact that Hip1R appears by electron microscopy to be
a dimer is supported by several previous observations. First,
endogenous Hip1R stripped from CCVs with 0.5 M Tris-
HCl migrated on a native gel filtration column close to AP2
(270 kD) (unpublished data), suggesting that Hip1R is a
dimer (240 kD). Second, Hip1R coimmunoprecipitates
with itself, even when clathrin is disassembled (Fig. 1 b).
Moreover, we have recently shown that Hip1R and Hip1
can interact with each other in the yeast two-hybrid system
(Chopra et al., 2000). Finally, studies on yeast Sla2p suggest
that it also dimerizes (Wesp et al., 1997; Yang et al., 1999).
In summary, Hip1R appears in vitro to be a rod-shaped
dimer some 60 nm in length, with globular heads at either
end. Hip1R appears to localize in situ to the surfaces or cir-
cumferences of clathrin-coated pits, and it often appears to
link coated pits with adjacent actin filaments.
 
Overexpression of Hip1R in Cos-7 cells causes 
redistribution of clathrin LC
 
We next investigated whether overexpression of Hip1R af-
fects clathrin distribution. To test this possibility, we overex-
pressed Hip1R–myc in Cos-7 cells and looked at the distri-
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bution of endogenous clathrin. In cells expressing high levels
of Hip1R–6myc, clathrin LC showed less punctate staining
at the cell cortex and appeared more diffuse in the cytosol
(Fig. 7, a–c). This affect was dose dependent because at low
expression levels, Hip1R–6myc and clathrin LC showed ex-
cellent colocalization (Fig. 7, d–f). Approximately 90% of
cells expressing high levels of Hip1R showed clathrin LC de-
localization (
 
n
 
 
 

 
 100). However, the redistribution of clath-
rin LC was specific, since overexpression of Hip1R (amino
acids 1–324)-6myc, which does not bind to clathrin in vitro
and does not coimmunoprecipitate with clathrin, did not
have this effect (Fig. 7, g–i). Only 5% of cells expressing high
levels of Hip1R (amino acids 1–324)-6myc showed clathrin
LC delocalization. Since clathrin LC is tightly associated with
clathrin HC in vivo, we also determined whether overexpres-
sion of Hip1R affected the distribution of clathrin HC. As
shown in Fig. 7, j–l, clathrin HC staining still appeared
punctate in cells expressing Hip1R at high levels, although in
some cells more of the clathrin HC appeared to be cytosolic.
Since overexpression of Hip1R affected the subcellular
distribution of clathrin LC, we also tested whether overex-
pression of clathrin LC affected localization of endogenous
Hip1R. In cells expressing high levels of DsRed–clathrin
LCa, Hip1R showed reduced punctate staining at the cell
cortex (Fig. 7, m–o).
 
Hip1R induces clathrin cage assembly in vitro
 
The data so far indicate that Hip1R is tightly associated with
clathrin at the plasma membrane, suggesting that Hip1R
might function during CCV formation. To address this possi-
bility, we tested whether Hip1R affects clathrin assembly in
vitro. Clathrin triskelia, alone and in the presence of Hip1R,
were dialyzed against a buffer that supports assembly of pure
clathrin only when assembly proteins are present (e.g., AP2,
AP180/CALM, auxilin, and GAK) (Ungewickell and Oester-
gaard, 1989; Ahle and Ungewickell, 1990; Keen, 1990). Fig. 8
b, lane 6, and c, show that when His
 
6
 
–Hip1R was added to the
assembly reaction, 40–50% of the clathrin was shifted from
the high speed supernatant to the high-speed pellet, suggesting
that Hip1R promoted clathrin assembly. This effect is similar
to what has been reported previously for AP2 (Goodman et al.,
1997) and for the auxilin-like domain of GAK (Fig. 8 a; Ahle
and Ungewickell, 1990) using similar buffer conditions. The
assembly of clathrin was not caused by the His
 
6
 
 tag since an-
other His
 
6
 
-tagged protein (His
 
6
 
–GAK kinase domain) did not
have this activity (Fig. 8 b, lane 7–9). Even a fourfold molar
excess of His
 
6
 
–GAK kinase domain to clathrin did not shift
clathrin to the high-speed pellet (unpublished data).
Electron microscopy of negatively stained aliquots of the
dialysate confirmed that Hip1R promoted clathrin cage as-
sembly (Fig. 8 d). The size distribution of these cages ranged
from 50–90 nm. 85% of the cages were 60–79 nm (Fig. 8
e). This is similar to what has been reported for other clath-
rin assembly factors (e.g., AP2 and AP180) (Ahle and Un-
gewickell, 1986; Keen, 1987).
 
Hip1R can physically link F-actin to clathrin cages 
in vitro
We have shown previously that the talin-like domain of
Hip1R binds to F-actin in vitro and colocalizes with F-actin
Figure 6. A gallery of anaglyph three-dimensional images. 
Images of Hip1R (rows 1–3, and 6), kinesin (rows 4 and 7), 
myosin II (row 5), and IgG (row 8) absorbed on mica and 
visualized by quick-freeze, deep-etch electron microscopy. 
The total length of the Hip1R molecule is 60 nm (7 nm) 
with a central long shaft spanning 40 nm (6 nm). At each 
end of the central shaft are pairs of 7–10-nm globular heads. 
We also observed Hip1R molecules that appeared kinked 
(row 6), a feature shared with kinesin (row 7). Magnification, 
28,000.
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in vivo (Engqvist-Goldstein et al., 1999). Our biochemical
and ultrastructural findings suggesting that Hip1R is a paral-
lel dimer raise the possibility that Hip1R could cross-link
clathrin and actin filaments to themselves and to each other.
To test this hypothesis, low speed pelleting of mixtures of
F-actin, Hip1R, and CCVs was performed. We first tested
whether full-length Hip1R binds to F-actin. As shown in
Fig. 9 a, lanes 15 and 16, mixtures of Hip1R and F-actin
copelleted at low speed, which suggests that Hip1R can
crosslink F-actin. We then mixed CCVs together with
Hip1R, which caused a shift of clathrin and Hip1R to the
low speed pellet (Fig. 9 a, lanes 17 and 18). Other compo-
nents of CCVs, AP2 and Eps15, also shifted to the low
speed pellet as determined by Western blotting (unpub-
lished data). Finally, we added CCVs together with F-actin
and Hip1R, which caused a shift of clathrin, Hip1R, and
F-actin to the low speed pellet (Fig. 9 a, lanes 19 and 20).
Thus, CCVs and actin do not appear to compete for bind-
ing to Hip1R, raising the possibility (tested below) that
Hip1R might crosslink actin filaments and CCVs to each
other. The Hip1R pelleting of CCVs appeared specific,
since another actin crosslinking protein, coronin (Goode et
al., 1999), did not cause a shift in clathrin pelleting (lanes
9–12), although it did crosslink actin filaments (lanes 7 and
8, and 11 and 12).
Since Hip1R alone caused a shift of CCVs to the low
speed pellet, we could not determine in the above experi-
ment whether Hip1R could link clathrin and F-actin
Figure 7. Overexpression of full-length 
Hip1R affects the distribution of 
clathrin LC. (a–l) Indirect immunofluo-
rescence of endogenous clathrin LC 
(red) or clathrin HC (red) in Cos-7 cells 
expressing myc-tagged Hip1R constructs 
(green). (a–c) In cells expressing high 
levels of Hip1R (amino acids 1–1068)-
6myc, clathrin LC is more diffuse and 
shows reduced staining at the cell
cortex. (d–f) At low expression of Hip1R 
(amino acids 1–1068)-6myc, clathrin LC 
colocalizes with Hip1R. (g–i) High 
expression of Hip1R (amino acids 
1–324)-6myc does not affect the 
distribution of clathrin LC. (j–l) Clathrin 
HC still shows a punctate staining 
pattern in cells expressing high levels of 
Hip1R (amino acids 1–1068). (m–o) 
Indirect immunofluorescence of endoge-
nous Hip1R (green) in Cos-7 cells 
expressing high levels of DsRed–clathrin 
LCa (red). Merged images are shown in 
the right column. Bars, 10 m.
1218 The Journal of Cell Biology | Volume 154, Number 6, 2001
physically. To address this question, we performed F-actin
pelleting assays using Hip1R-assembled clathrin cages in-
stead of CCVs. Under buffer conditions used for F-actin
pelleting, 30–40% of clathrin cages assembled with
Hip1R pelleted at low speed (Fig. 9 b, lanes 3 and 4). Ad-
dition of F-actin resulted in 100% of the Hip1R-assem-
bled clathrin cages pelleting at low speed and a shift
of F-actin from the high speed pellet to the low speed
pellet (Fig. 9 b, lanes 5 and 6). This effect appeared spe-
cific since GAK (auxilin-like domain)-assembled clathrin
cages did not shift to the low speed pellet upon adding
F-actin (Fig. 9 b, lanes 9 and 10). Furthermore, GAK
(auxilin-like domain)-assembled clathrin cages did not
cause a shift of F-actin to the low speed pellet (Fig. 9 b,
lanes 9 and 10). Taken together, these results demon-
strate that Hip1R can physically link F-actin and clathrin
cages in vitro.
Discussion
We have shown previously that Hip1R is a component of
clathrin-coated pits and vesicles that may link the endocytic
machinery to the actin cytoskeleton (Engqvist-Goldstein et
al., 1999). To date, very little is known about how the mem-
bers of Sla2/Hip1 family interact with the endocytic ma-
chinery. Here, we showed that Hip1R binds directly to
clathrin cages with high affinity and coimmunoprecipitates
with clathrin from cell and tissue extracts. Furthermore,
Figure 8. Hip1R promotes clathrin cage assembly in vitro. 
(a) Clathrin (400 nM) was dialyzed overnight in the absence (CL) 
or presence of an equimolar quantity of His6–GAK auxilin-like 
domain (Gaux). Equal proportions of the low speed pellet (LP), 
high speed supernatant (HS), and high speed pellet (HP) were 
run on an SDS-PAGE gel which was then stained with 
Coomassie blue. (b) Clathrin (200 nM) was dialyzed overnight 
in the absence (CL) or presence of an equimolar quantity of 
His6–Hip1R or His6–GAK kinase domain (control) as indicated. 
Equal proportions of the low speed pellet (LP), high speed 
supernatant (HS), and high speed pellet (HP) were run on an 
SDS-PAGE gel and stained with Coomassie blue. (c) The graph 
shows the relative amount of clathrin HC in low speed pellet, 
high speed supernatant, and high speed pellet using data from 
three independent experiments. Clathrin HC was quantified by 
densitometry. Values are expressed as the fraction of total input 
clathrin. Error bars denote SE. (d) Electron microscopy of negatively stained clathrin coat structures formed in the presence of His6–
Hip1R. (e) Histogram of coat sizes formed in the presence of His6–Hip1R (n  100). Bar, 100 nm.
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Hip1R and clathrin show a remarkably similar temporal and
spatial regulation at the cell cortex in live cells. Not only do
these proteins show a very similar localization pattern, but
they appear and disappear at the cortex together, within the
time resolution of these experiments. The appearance of
clathrin puncta at the cortex is likely to reflect assembly of
clathrin-coated pits (Gaidarov et al., 1999). These data sug-
gest that Hip1R is recruited to the cell cortex during early
stages of endocytosis. Further support for this conclusion
comes from data showing that Hip1R localizes to coated pits
at the ultrastructural level. Anti-Hip1R antibodies specifi-
cally labeled two-dimensional clathrin lattices and invagi-
nated clathrin-coated pits in “unroofed” cells.
Similar to other endocytic proteins present in clathrin-
coated pits (e.g., AP2, AP180) (Ungewickell and Oester-
gaard, 1989; Keen, 1990), Hip1R promotes assembly of
clathrin in vitro. Although we currently do not know
whether the clathrin assembly promoting activity of Hip1R
is important in vivo, our data so far clearly demonstrate that
Hip1R associates with assembled clathrin in vivo. AP2 and
AP180 are both major components of the clathrin coat, in-
volved in recruiting clathrin to the plasma membrane
through interactions with PI(4,5)P2, and, in the case of AP2,
through interactions with receptors (for review see Marsh
and McMahon, 1999; Brodin et al., 2000). Recent efforts to
reconstitute the early stages of endocytosis in vitro showed
that the minimal requirements for the initial stage of coated
pit invagination are clathrin, AP2, AP180, and PIP2-con-
taining membranes (Ford et al., 2001). However, with these
components the pits did not invaginate completely, suggest-
ing that additional components may be required for forma-
tion of coated pits (Ford et al., 2001). Hip1R may be re-
quired to form coated pits with proper morphology and
might affect the kinetics of pit formation. In addition, since
the actin cytoskeleton is an integral part of the cell cortex
and has been implicated in early stages of endocytosis, the
actin-binding properties of Hip1R might affect coated pit
formation in vivo.
The putative central coiled-coil domain of Hip1R inter-
acts with clathrin. The coiled-coil domain copelleted with
clathrin cages in vitro and coimmunoprecipitated from ex-
tracts with clathrin. Furthermore, the Hip1R coiled-coil do-
main partially colocalized with clathrin. The Hip1R coiled-
coil domain does not contain the clathrin binding motifs
L(L,I)(D,E,N)(L,F)(D,E), referred to as the “clathrin box,”
or the shorter DLL motif found in many proteins that inter-
act with the TD of clathrin HC (Dell’Angelica et al., 1998;
Morgan et al., 2000; ter Haar et al., 2000). Consistent with
these observations, we did not detect any binding of Hip1R
to the TD of clathrin. Instead, our in vitro binding studies
Figure 9. Hip1R can physically link 
F-actin and clathrin in vitro. (a) Hip1R 
crosslinks F-actin and CCVs. SDS-PAGE 
of a low speed F-actin cosedimentation 
assay. Equal proportions of the low 
speed pellet (P) and low speed super-
natant (S) were run on an SDS-PAGE 
gel which was then stained with 
Coomassie blue. Different components 
(2 M F-actin, 0.5 M Hip1R, 0.5 M 
coronin (cor), and 0.2 mg/ml CCVs) 
were included in the assay as indi-
cated at the top of the gel. (b) Clathrin 
cages assembled with Hip1R copellet 
with F-actin at low speed. Clathrin 
(200–400 nM) was dialyzed overnight 
in the presence of an equimolar quan-
tity of either His6–Hip1R (200 nM) or 
His6–GAK auxilin-like domain (400 
nM). The Hip1R–clathrin cages and 
the auxilin–clathrin cages were then 
tested in an F-actin copelleting assay. 
Equal proportions of the low speed 
pellet (L) and the high speed pellet (H) 
were run on an SDS-PAGE gel which 
was then stained with silver. Lanes 1 
and 2 show F-actin alone. Lanes 3 and 
4 show clathrin cages assembled with 
Hip1R. Lanes 5 and 6 show clathrin 
cages assembled with Hip1R plus 
F-actin. Lanes 7 and 8 show clathrin 
cages assembled with the auxilin-like 
domain of GAK. Lanes 9 and 10 show 
clathrin cages assembled with the 
auxilin-like domain of GAK plus 
F-actin. The data shown are representa-
tive of three independent experiments.
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suggest that LCs contribute to the binding of Hip1R to
clathrin. Truncated cages reconstituted with LCs restored
Hip1R binding to clathrin. Furthermore, overexpression of
Hip1R affected the subcellular distribution of endogenous
clathrin LC in vivo. In cells expressing high levels of Hip1R,
clathrin LC appeared more diffuse and there were fewer
large puncta at the cortex. This may result if Hip1R binds to
LC and sequesters LC in the cytosol. An alternative possibil-
ity that we considered is that Hip1R blocks the access of
clathrin LC antibody by binding tightly to LC. However, we
favor the former possibility because clathrin LC antibody
can immunoprecipitate clathrin cages saturated with Hip1R
in vitro (unpublished data).
Although the localization of clathrin LC was affected by
Hip1R overexpression, clathrin HC localization appeared es-
sentially normal. However, we cannot exclude the possibility
that there was a partial redistribution of the HC that would
be difficult to detect by light microscopy. In light of the re-
distribution of clathrin LC, it is surprising that there was no
detectable reduction in internalization of transferrin in cells
overexpressing Hip1R (unpublished data). One possibility is
that Hip1R only partially competes and/or sequesters clathrin
LC from coated pits and that the remaining LC can maintain
clathrin function. It is interesting to note that clathrin LCs
are thought to inhibit HC assembly, so that lattice formation
does not spontaneously occur under physiological conditions
(Ungewickell and Ungewickell, 1991; Ybe et al., 1998). Since
Hip1R binding to truncated clathrin cages depends on LC,
Hip1R might promote clathrin assembly via interactions
with LC.
A Hip1R fragment containing the NH2-terminal region
plus the coiled-coil domain colocalized with clathrin in cells
much better than the coiled-coil domain alone. This sug-
gests the coiled-coil domain alone is not sufficient for proper
association of Hip1R with clathrin-coated pits and vesicles.
However, the NH2-terminal region alone did not colocalize
with clathrin, although it localizes to patches at the cell cor-
tex. The NH2-terminal region contains an ENTH-like do-
main and a region of 150 amino acids that is conserved
within the Sla2/Hip1 family. The ENTH-like domain of
the Sla2/Hip1 family members is similar to domains of
AP180/CALM, which have been shown recently to interact
with PI(4,5)P2 at the plasma membrane (Ford et al., 2001).
Because all of the CALM residues implicated in PI(4,5)P2
binding are conserved in Hip1R, it is highly likely that
Hip1R also associates with PI(4,5)P2 (Ford et al., 2001).
This activity may increase the affinity of Hip1R for coated
pits, as has been shown for other endocytic proteins (e.g.,
AP2) that bind to PIP2 (Gaidarov and Keen, 1999). In yeast,
it has also been shown that both the NH2-terminal region
and the coiled-coil domain of Sla2p are important for en-
docytosis (Wesp et al., 1997).
Studies on clathrin dynamics in vivo have suggested that
the actin cytoskeleton might provide a scaffold at the plasma
membrane for the endocytic machinery. Depolymerization
of F-actin caused an increase in the lateral movement of
clathrin-coated pits (Gaidarov et al., 1999). There is also ev-
idence that in some cell types, depolymerization of F-actin
traps CCVs before detachment from the plasma membrane
(Lamaze et al., 1997). Our previous data suggested that
Hip1R may provide a link between the endocytic machinery
and F-actin (Engqvist-Goldstein et al., 1999). We now dem-
onstrate that full-length Hip1R can directly link F-actin and
clathrin in vitro. Clathrin cages assembled with Hip1R
shifted from the high speed pellet to the low speed pellet
when F-actin was included in the reaction. Furthermore,
Hip1R copelleted with both F-actin and CCVs at low speed,
demonstrating that Hip1R promotes assembly of clathrin
and F-actin into higher order structures in vitro. Immunolo-
calization of Hip1R to the interface between clathrin-coated
pits and actin filaments in “unroofed” cells provides support
for the in vivo relevance of this activity.
Our biochemical data are consistent with the structural
analysis of Hip1R, showing that it is a rod-shaped apparent
dimer with globular heads at either end, spanning 60 nm in
length. These globular heads are presumably the NH2-termi-
nal region, which contains the ENTH-like domain, and the
COOH-terminal region, which contains the talin-like actin
binding domain. Therefore, a Hip1R dimer may bind to at
least two actin filaments and two clathrin molecules, thereby
creating higher order complexes which would associate with
the plasma membrane via interactions of the ENTH-like do-
main with PIP2. Since Hip1R can also promote assembly of
clathrin cages in vitro, we speculate that Hip1R could assem-
ble clathrin on the lipid bilayer. In total, Hip1R’s properties
suggest that it may act as a scaffolding protein at the interface
between clathrin, F-actin, and lipids during endocytosis.
Materials and methods
DNA constructs
Full-length Hip1R (amino acids 1–1068), Hip1R (amino acids 1–655),
Hip1R (amino acids 346–1068), and the auxilin and kinase domains of
GAK were expressed with an His6 tag at the NH2 terminus in Sf9 cells.
Hip1R (amino acids 1–1068), Hip1R (amino acids 1–655), and Hip1R
(amino acids 346–1068) were amplified by PCR using primers that gener-
ate Sal1 and Not1 sites at the 5	 and 3	 ends, respectively. The PCR prod-
ucts were then ligated into pFASTBAC Hta (GIBCO BRL). Recombinant
baculoviruses were generated according to the manufacturer (GIBCO BRL).
For in vitro clathrin cage binding assays, Hip1R fragments were expressed
as GST fusion proteins in E. coli. Hip1R (amino acids 1–312) was amplified
by PCR using primers that generate BamHI and NsiI sites at the 5	 and 3	
ends, respectively. Hip1R (amino acids 346–655) was amplified using prim-
ers that generate XhoI and HindIII sites at the 5	 and 3	 ends, respectively.
The PCR products were cut with the above restriction enzymes and ligated
into the pGAT2 as described in (Engqvist-Goldstein et al., 1999).
Construction of GST-TD of clathrin (amino acids 1–579) was described
in Goodman et al. (1997).
For expression of Hip1R constructs in mammalian cells, full-length pro-
tein (amino acids 1–1068) and fragments of Hip1R were expressed as GFP
fusions, or were expressed with an myc tag at the COOH terminus. Hip1R
(amino acids 325–655)-6myc was constructed as described in Engqvist-
Goldstein et al. (1999). Construction of Hip1R (amino acids 1–1068)-GFP,
Hip1R (amino acids 1–1068)-6myc, Hip1R (amino acids 1–324)-6myc,
Hip1R (amino acids 1–655)-6myc, Hip1R (amino acids 346–1068)-6myc,
and Hip1R (amino acids 766–1068)-6myc were described in Engqvist-
Goldstein et al. (1999). All constructs were sequenced to ensure that no
mutations were introduced during PCR.
Expression and purification of recombinant proteins
Expression in insect cells (Sf9) and purification of His6-tagged full-length
Hip1R (amino acids 1–1068), Hip1R (amino acids 1–655), Hip1R (amino
acids 346–1068), GAK (auxilin-like domain), and GAK (kinase domain),
were done according to the manufacturer (GIBCO BRL). Pooled fractions
containing pure proteins were dialyzed overnight in 1 L of HEKG buffer
(20 mM K-Hepes, pH 7.4, 1 mM EDTA, 50 mM KCl, 5% glycerol) contain-
ing 0.4 mM PMSF with one exchange of buffer, snap frozen in liquid N2
and stored at 80
C.
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GST–Hip1R (amino acids 1–312), GST–Hip1R (amino acids 346–655),
GST–Hip1R (amino acids 766–1068), GST-TD of clathrin HC (amino acids
1–579) and GST alone were expressed in E. coli and purified as described
in Engqvist-Goldstein et al. (1999).
Immunoprecipitations
For immunoprecipitation from brain extracts, five mouse brains (Pel-Freez
Biologicals) were minced using a razor blade and homogenized at 4
C us-
ing a dounce glass homogenizer (size AA; 20 strokes). For homogeniza-
tion, 2 ml/g tissue homogenization buffer (10 mM Hepes, pH 7.4, 1 mM
EDTA) containing protease inhibitors cocktail A (10 g/ml leupeptin, 10
g/ml aprotinin, 10 g/ml soybean trypsin inhibitors, and 1 mM PMSF)
was used. The samples were centrifuged at 4
C for 50 min at 7,500 rpm in
a SA-600 rotor (Beckman Coulter). The resulting supernatant fraction was
then centrifuged at 4
C for 50 min at 55,000 rpm in a TLA 100.3 rotor
(Beckman Coulter). The pellet was resuspended in 1.2 mL buffer A (20 mM
Hepes, pH 7.4, 1 mM EDTA, 5 mM MgCl, 50 mM KCl, 1% NP-40) con-
taining the protease inhibitor cocktail A and homogenized as described
above. The extract was then spun at 4
C for 15 min at 15,000 rpm in a mi-
crocentrifuge. Antibodies were then added to 200 L of extract and incu-
bated at 4
C on a rotating platform. After 2 h, swollen protein A or protein
G beads were added to the extract/antibody mixture (30 L of 50% slurry)
and incubated an additional 1.5 h at 4
C on a rotating platform. The super-
natant (200 L) was collected and mixed with 100 L 3 SDS sample
buffer and boiled. The beads were washed three times with 1 mL of buffer
A and then resuspended in 300 uL of SDS sample buffer and boiled. Equal
portions of homogenate, supernatant (S), and pellet (P) were loaded on
SDS-PAGE gels and analyzed by immunoblotting.
For immunoprecipitation from cell extracts, Cos-7 cells were plated at
1.5  106 cells per T-75 flask. Transfections were performed using the li-
pofectamine method according to the manufacturer (GIBCO BRL). 36 h af-
ter transfection, cells were washed once with PBS, pH 7.4, and incubated
on ice. To lyse the cells, 0.2 ml of cold lysis buffer (20 mM Hepes, pH 7.4,
1 mM EDTA, 50 mM KCl, 1% NP-40) containing protease cocktail A was
added directly to the plates and cells were scraped off and homogenized
by passaging through a 27-gauge needle. Immunoprecipitations were per-
formed as described above. The beads were resuspended in 20 L of SDS
sample buffer and boiled. For treatment with 0.5 M Tris-HCl, beads were
washed an additional three times with the same buffer with or without
0.5 M Tris-HCl. Equal volumes of homogenate and beads were loaded on
SDS-PAGE gels and analyzed by immunoblotting.
The following antibodies were used for immunoprecipitation experi-
ments. Polyclonal anti-Hip1R (GP#8; Engqvist-Goldstein et al., 1999)
was used at 1:20; monoclonal anti–-adaptin antibody (AP.6; Affinity
BioReagents, Inc.) was used at 1:100; polyclonal anti-Eps15 antibody
(Transduction Laboratories) was used at 1:100; polyclonal anti-myc anti-
body (Santa Cruz Biotechnology, Inc.) was used at 1:100; and polyclonal
anti-GFP antibody (provided by Dr. Pam Silver and Dana Farber, Harvard
Medical School, Cambridge, MA) was used at 1:500. The following anti-
bodies were used for Western blotting. Polyclonal anti-Hip1R antibodies
(GP#8 and GP#6) were used at 1:1,000; monoclonal anti–-adaptin anti-
body (AC1-M11; Affinity BioReagents, Inc.) was used at 1:1,000; poly-
clonal anti-Eps15 antibody was used at 1:2,000; monoclonal anticlathrin
antibody (Transduction Laboratories) was used at 1:1,000; monoclonal an-
tidynamin antibody (hudy 1; Upstate Biotechnology) was used at 1:2,000;
monoclonal anti-myc antibody (9E10; Santa Cruz Biotechnology, Inc.) was
used at 1:1,000; polyclonal anti-GFP antibody was used at 1:20,000; and
polyclonal amphiphysin II antibody (provided by Harvey T. McMahon,
MRC Laboratories, Cambridge, UK) was used at 1:2,000.
Clathrin cage binding assays
To obtain pure clathrin for binding assays, clathrin triskelia were purified
from bovine brain. First, CCVs were purified as described in Engqvist-
Goldstein et al. (1999). Then clathrin was purified from CCVs as described
(Zaremba and Keen, 1983). Fractions containing only clathrin heavy chain
(HC) and light chain (LC), as judged by Coomassie-stained gels, and no de-
tectable levels of AP2, as judged by immunoblotting, were used for assem-
bly of clathrin cages. Preparation of intact and truncated clathrin cages re-
constituted with clathrin LCs has been described elsewhere (Keen et al.,
1991). Hip1R binding to cages was performed as described in Goodman et
al. (1997). In brief, full-length Hip1R or Hip1R domains were incubated in
the presence of clathrin cages in buffer B (0.1 M Mes, pH 6.5, 1 mm EGTA,
0.5 mm MgCl2) for 10 min at room temperature. Complexes were centri-
fuged through a 50 L 0.2 M sucrose cushion prepared in buffer B using a
TLA100 rotor (Beckman Coulter) at 75,000 rpm for 5 min at 4
C and ana-
lyzed on 8.5% SDS-PAGE gels by Coomassie staining or immunoblotting.
Hip1R bands were quantified by densitometry.
GST-TD binding assay
GST and GST-TD of clathrin (0.5 M) in a 15-l bed volume of glu-
tathione-agarose and His6–Hip1R (0.1 M) were incubated in 100 l 20
mM Hepes, pH 7.4, 1 mM EDTA, 50 mM KCl for 1 h at 4
C on a rotator.
The beads were then centrifuged and washed three times with 1 ml of the
same buffer containing 1% Triton X-100 and 100 mM KCl and eluted with
SDS-PAGE sample buffer and analyzed on 8.5% SDS-PAGE gels by Coo-
massie staining.
Transfection of COS-7 cells with cDNA encoding Hip1R and 
clathrin fusion proteins
Transfections were performed using the lipofectamine method according
to the manufacturer (GIBCO BRL). Typically, 1 g of DNA per T-25 flask
was used. Transfections were performed for 5 h at 37
C. The solution was
then replaced by complete medium (DME containing 10% FBS). After 3 h,
cells were trypsinized and replated on coverslips at 20–30% confluency.
Approximately 36 h later, cells were processed for immunofluorescence or
for imaging of Hip1R–YFP and DsRed–clathrin-LCa in living cells or for
transferrin uptake assay.
Cell culture and indirect immunofluorescence
Cell culture and immunofluorescence were performed as described in (Eng-
qvist-Goldstein et al., 1999). The following primary antibodies were used:
polyclonal anti-Hip1R antibody (GP#8) was used at 1:20; monoclonal
anti–-adaptin antibody (AP.6) and monoclonal anti-clathrin antibody
(X22; Affinity Bioreagents, Inc.) were used at 1:150; monoclonal anticlath-
rin LC antibody (CON.1; Covance Research Products) was used at 1:200;
monoclonal anti-myc antibody (9E10) was used at 1:4,000; and polyclonal
anti-myc antibody (Santa Cruz Biotechnology, Inc.) was used at 1:400. The
following secondary antibodies were used. FITC goat anti–guinea pig (ICN
Biomedicals); FITC donkey anti–mouse (Jackson ImmunoResearch Labora-
tories); rhodamine donkey anti–mouse (Jackson ImmunoResearch Labora-
tories); FITC donkey anti–rabbit (Jackson ImmunoResearch Laboratories);
rhodamine donkey anti–rabbit (Jackson ImmunoResearch Laboratories).
The coverslips were viewed using an inverted fluorescence microscope
(Eclipse TE300; Nikon). Images were captured using a Hamamatsu ORCA
cooled CCD camera. Images were recorded digitally (Phase3 Imaging Sys-
tems; ImageProPlus). All images were prepared for publication using
Adobe Photoshop® software.
Imaging of Hip1R–YFP and DsRed–clathrin-LCa in living cells
Cos-7, HeLa, and CHO cells were transfected with Hip1R–GFP or Hip1R–
YFP and DsRed–clathrin-LCa as described above. Cells were grown on un-
coated 35-mm coverslip dishes (MatTek Corporation), and transferred to me-
dium containing 25 mM Hepes, pH 7.4, before viewing. The microscope
stage was fitted with an open perfusion microincubator attached to a tem-
perature controller (Harvard Apparatus) maintained at 37
C for the duration
of the experiment, unless stated otherwise. Temperature of the viewing ob-
jective (Plan-Apo 1.40 NA 63 oil immersion lens; ZEISS) was monitored
separately with a YSI Precision 4000A Thermometer and regulated with an
external heater fan. Images were collected on a Quantix cooled, CCD cam-
era containing either a Kodak 1400 chip, or the newer Kodak 1401E chip
(Photometrics), yielding a pixel size of 108 nm for all images. GFP and YFP
were visualized using specific individual filter sets for each fluorophore
(Chroma). To image YFP and DsRed1, excitation/emission filter sets were
switched between FITC and Texas red (TxRd), using a common FITC/TxRd
double dichroic mirror (Chroma). Excitation light originated from a 100-W
mercury lamp, and was attenuated to 32% with a neutral density filter. Filter
wheels (dual or single 6-position wheels with shutter; Ludl Electronic Prod-
ucts) were mounted on the excitation and emission ports of the microscope
and were controlled with IPLab software (Scanalytics). All images were pro-
cessed for analysis with IPLab and Photoshop® (Adobe).
To collect high quality images with good sensitivity, cells were photo-
graphed by rapidly alternating excitation/emission filters (YFP/DsRed1),
and exposing for 0.4–1.0 s to capture each fluorescent marker individu-
ally. The resulting data consisted of two image stacks (one for each
marker), where frame 1 of stack 1 was the first image taken, frame 1 of
stack 2 was the second image, frame 2 of stack 1 was third, and so on. For
analysis, each grayscale frame from stack 1 (green) was color merged with
the same frame number in stack 2 (red), to create a pseudosimultaneous
color stack.
Immunogold labeling of “unroofed” cells
Labeling of “unroofed” cells with anti-Hip1R antibodies was performed as
described in (Heuser, 1989b, 2000b). In brief, PC12 and Cos-7 cells were
grown on carbon-coated glass and “unroofed” by brief exposure to an ul-
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trasonic burst in “KHMgE medium” (70 mM KCl, 30 mM Hepes buffer, pH
7.2, 5 mM MgCl2, and 3 mM EGTA). Immediately after “unroofing,” the
cells were fixed for 30 min in 2% formaldehyde freshly dissolved from
paraformaldehyde into KHMgE medium, “quenched” for 10 min with 50
mM lysine and 50 mM glycine in KHMgE, and labeled for 1 h each with
anti-Hip1R antibody (GP#8) at 1:10 dilution followed by a commercial 15-
nm gold-tagged secondary antibody. Samples were then processed by
quick-freezing, freeze-drying, platinum replication in preparation for view-
ing in the electron microscope. For stereomicroscopy, the replica was
mounted in the eucentric side-entry goniometer stage of a JEOL 200CX
electron microscope, imaged at 20,000–70,000, and photographed at
10
 of tilt off the vertical axis. For preparation of digital “anaglyph” three-
dimensional images from the resultant stereo pairs of EM negatives, see
Heuser (2000a,c).
Deep-etch technique for macromolecules adsorbed to 
mica flakes
Purified His6–Hip1R (10 g/ml) was briefly adsorbed to freshly cleaved
mica and then quick-frozen, freeze-fractured, and deep-etched as de-
scribed previously (Heuser, 1983, 1989a). Replicas were viewed in a JEOL
200CX transmission electron microscope operated at 100 kV, and stereo
images were obtained using 10
 of tilt with an eucentric side-entry goni-
ometer stage. Final digital “anaglyph” three-dimensional images were gen-
erated by making digital copies of stereo pairs of standard EM negatives
and merging them together in separate colors with Adobe Photoshop®, as
described in Heuser (2000a).
Clathrin assembly assay
Clathrin assembly assays have been described (Keen, 1987; Goodman et
al., 1997). In brief, clathrin triskelia (100–400 nM) was dialyzed overnight
in 0.1 M Na-MES, pH 6.8, containing 0.1 mM PMSF in the presence of
0–400 nM His6–Hip1R (amino acids 1–1068) and/or 0–800 nM of His6–GAK
(kinase domain) and/or 400 nM of His6–GAK (auxilin-like domain) using
a Slide-A-Lyzer (Pierce Chemical Co.). The dialyzates were microcentri-
fuged at 10,000 g for 2 min (generating low speed pellet and supernatant
fractions) and then at 75,000 rpm for 5 min in a TL100 rotor (generating
high speed pellet and supernatant fractions). Equal portions of the fractions
were analyzed on 8.5% SDS-PAGE, and clathrin HC was quantified by
densitometry of Coomassie blue staining. Aliquots of the dialyzate were
also stained with 1% uranyl acetate and viewed in a FEI Tecnai 12 (120
kV) transmission electron microscope.
Assay for F-actin pelleting with CCVs
Low speed F-actin cosedimentation assays were performed as described in
Goode et al. (1999) with minor alterations. In brief, 2 M rabbit skeletal
muscle actin (Cytoskeleton, Inc.) was incubated with 0.2 mg/mL CCVs (pu-
rified from mouse brain), and/or 0.5 M Hip1R and/or 0.5 M yeast coro-
nin in actin polymerization buffer (5 mM Tris-HCl, pH 7.5, 0.2 mM DTT,
0.2 mM CaCl2, 0.7 mM ATP, 150 mM KCl, 2 mM MgCl2) for 30 min at
room temperature in a final volume of 30 l. The samples were then spun
for 5 min at 14,000 rpm in a tabletop centrifuge. The supernatant (30 L)
was collected and mixed with 15 L 3 SDS sample buffer and boiled.
The pellets were resuspended in 45 L 1 SDS sample buffer and boiled.
Equal portions of supernatant (S) and pellet (P) samples were loaded on
SDS-PAGE gels.
Assay for F-actin pelleting with clathrin cages
Clathrin cages were assembled with Hip1R or with the auxilin-like domain
of GAK as described above (see clathrin assembly assay). The dialyzates
were then centrifuged at 75,000 rpm for 5 min in a TL100 rotor and resus-
pended in buffer B (0.1 M MES, 1.0 mM EGTA, 0.5 mM MgCl2, pH 6.5). To
remove any aggregates, the cages were spun for 5 min at 14,000 rpm in a
tabletop centrifuge. F-actin (1.25 M) was polymerized in a final volume
of 30 l for 30 min as described above (see F-actin pelleting assays with
CCVs). 10 L of the assembled clathrin cages, containing either Hip1R or
the auxilin-like domain of GAK, were added to the polymerized actin and
incubated for an additional 10 min at room temperature. The samples
were then centrifuged through a 50 l 0.2 M sucrose cushion prepared in
buffer B at 10,000 g for 5 min (generating low speed pellet and supernatant
fractions) and then at 75,000 rpm for 5 min in a TL100 rotor (generating
high speed pellet and supernatant fractions). Equal portions of the fractions
were analyzed on 8.5% SDS-PAGE gels by Coomassie staining.
Online supplemental material
The video shows time-lapse analysis of Hip1R–YFP (green) and DsRed–
clathrin-LCa (red) coexpressed in a Cos-7 cell. We observed individual
puncta at the cell cortex at 3 s intervals over 60 frames, where the lag be-
tween Hip1R and clathrin visualization is 1.5 s. At this time resolution,
Hip1R and clathrin appear (arrow) and disappear (arrowhead) together.
The first frame of this video is shown in Fig. 4 c. Additional frames of a se-
lected area of this cell are shown in Fig. 4 f. The video was accelerated 15
times in relation to real time. The video is available at http://www.jcb.org/
content/vol154/issue6.
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